Jeff Reeves
Jeff Reeves (RSS)
Executive Editor of

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for since the beginning of 2010.  

Read complete bio
Recent Articles

Barracuda Networks Inc. (NYSE:CUDA) a Big Buy after Earnings

Oct. 12, 2016, 9:20 am EDT – Barracuda Networks Inc. (NYSE:CUDA) just posted strong earnings, and CUDA stock is a great buy amid a focus on cybersecurity. More 

Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!

Oct. 11, 2016, 9:38 am EDT – Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report. More 

7 Stock Charts to Watch in October

Sep. 29, 2016, 2:04 pm EDT – These seven stock charts tell a few stories, including a few unknown companies that could break higher and a few big-name stocks that could fall apart. More 

The 10 Best S&P 500 Stocks of Q3 2016

Sep. 27, 2016, 3:40 pm EDT – The best S&P 500 stocks of 2016 are mostly being driven by just two trends. Here's a look at the year's best stocks, and why they're soaring. More 

Stock Research: Intimidating, But Vital

Sep. 21, 2016, 3:50 pm EDT – Research is imperative for making the best stock picks you possibly can. But you're not sure how to start? Look no further. More 

I Just Bought JNUG Before the FOMC – Here’s Why

Sep. 15, 2016, 10:56 am EDT – Direxion's JNUG, a leveraged gold miner ETF, has slumped more than actual gold bullion prices. If there's no rate hike, it should soar next week. More 

7 Stock Splits Investors Are Dying to See

Sep. 13, 2016, 2:52 pm EDT – Stock splits wouldn't change a thing about these seven companies, but they would provide a much-needed shift in sentiment. More 

Why Don’t You Just Buy Facebook Stock, Dammit? (FB)

Sep. 8, 2016, 9:17 am EDT – FB stock is a perpetual outperformer, and Facebook earnings always show impressive growth. So why don't you just buy the stock already? More 

The 7 Best Monthly Dividend Stocks to Buy Now

Sep. 7, 2016, 2:14 pm EDT – These monthly dividend stocks don't just offer frequent bursts of high income -- they also can tack on gains through pure share appreciation, too. More 

Danaher Corporation (DHR) Buys Cepheid (CPHD): Who’s Next?

Sep. 6, 2016, 9:23 am EDT – Genetic testing biotech stocks are in focus after Danaher (DHR) bought out Cepheid (CPHD). ILMN, MYGN or QGEN stock could be acquired next! More